Clemens W.G.M. Löwik

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Kenneth Poole, Rutger L. van Bezooijen, N. Loveridge et al. · The FASEB Journal · 2005 · 954 citations

Adult Iliac Bone, Sclerostin, Bone Formation +16

Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist

Rutger L. van Bezooijen, Bernard A.J. Roelen, Annemieke Visser et al. · The Journal of Experimental Medicine · 2004 · 876 citations · Full text

Sclerostin, Bone Surface, Immunology +21

Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A

Martine Deckers, Rutger L. van Bezooijen, Geertje van der Horst et al. · Endocrinology · 2002 · 610 citations

Sclerostin, Endothelial Cells, Osteogenesis +17

BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis

Marion Scharpfenecker, Maarten van Dinther, Zhen Liu et al. · Journal of Cell Science · 2007 · 535 citations

Expression of Vascular Endothelial Growth Factors and Their Receptors during Osteoblast Differentiation

Martine Deckers, Marcel Karperien, Chris van der Bent et al. · Endocrinology · 2000 · 529 citations

Sclerostin, Angiogenesis, Osteoblast Differentiation +14